Twist Bioscience

US · TWST #1258 by market cap Listed 2018

155.65 -11.32 -6.78%

Live - 5344 symbols - heartbeat 285s ago · 2026-10-08 06:39

Pre-market 152.00 -2.35%

After-hours 155.50 -0.10%

Overnight 154.61 -0.67%

Market cap: 10.32B
P/E (TTM): -69.80
P/B: 23.15
EPS: -1.30
Div yield: 0.00%
52W pos: 67%

Reader sentiment Are you bullish or bearish on TWST?

Anonymous reader poll. Unscientific, not investment advice.

About Twist Bioscience

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Founded: 2013
CEO: Dr. Emily M. Leproust, PhD
Employees: 979
Headquarters: San Francisco, California, United States of America
Fiscal year end: 09-30
Website: twistbioscience.com

Company profile

Exchange: US
Symbol: TWST
Market-cap rank: #1258
Listing date: 2018-10-31
Market cap: 10.32B
Float cap: 10.18B
Shares out: 66.30M
Float shares: 65.42M

Sectors & themes

Biotechnology ARK Portfolio AI medical concept stocks Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 06:39:30 · For reference only, not investment advice and not tailored to your situation.